Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.
Goc J, Lv M, Bessman NJ, Flamar AL, Sahota S, Suzuki H, Teng F, Putzel GG; JRI Live Cell Bank; Eberl G, Withers DR, Arthur JC, Shah MA, Sonnenberg GF.
Goc J, et al. Among authors: arthur jc.
Cell. 2021 Sep 16;184(19):5015-5030.e16. doi: 10.1016/j.cell.2021.07.029. Epub 2021 Aug 17.
Cell. 2021.
PMID: 34407392
Free PMC article.